Medline Inc. (MDLN)
NASDAQ: MDLN · Real-Time Price · USD
38.87
+1.10 (2.91%)
At close: Jun 26, 2026, 4:00 PM EDT
38.88
+0.01 (0.03%)
After-hours: Jun 26, 2026, 7:40 PM EDT

Medline Stock Forecast

Stock Price Forecast

The 25 analysts with 12-month price forecasts for Medline stock have an average target of 51.12, with a low estimate of 38 and a high estimate of 62. The average target predicts an increase of 31.52% from the current stock price of 38.87.

Analyst Consensus: Buy
Target Low Average Median High
Price $38 $51.12 $53 $62
Change -2.24% +31.52% +36.35% +59.51%

Analyst Ratings

The average analyst rating for Medline stock from 28 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy 171617171717
Buy 566677
Hold 455544
Sell 000000
Strong Sell 000000
Total 262728282828

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Bank of America Securities
Bank of America Securities
Buy
Maintains
n/a
Buy Maintains n/a n/a Jun 22, 2026
William Blair
William Blair
Buy
Maintains
n/a
Buy Maintains n/a n/a Jun 12, 2026
Leerink Partners
Leerink Partners
Buy
Maintains
$56$52
Buy Maintains $56$52 +33.78% Jun 12, 2026
BTIG
BTIG
Buy
Reiterates
$55
Buy Reiterates $55 +41.50% Jun 9, 2026
Robert W. Baird
Robert W. Baird
Buy
Maintains
$45
Buy Maintains $45 +15.77% Jun 2, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
31.09B
from 28.43B
Increased by 9.34%
Revenue Next Year
34.91B
from 31.09B
Increased by 12.31%
EPS This Year
1.51
from 1.79
Decreased by -15.63%
EPS Next Year
1.67
from 1.51
Increased by 10.23%
Fiscal Year FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028
Period Ending Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027 Dec 31, 2028
Revenue
21.45B23.23B25.51B28.43B31.09B34.91B36.05B
Revenue Growth
-8.31%9.80%11.47%9.34%12.31%3.26%
EPS
-0.010.071.431.041.311.42
EPS Growth
--413.80%1,982.77%-26.99%24.99%8.64%
Forward PE
----37.2129.7727.40
No. Analysts ----252518
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202620272028
High 31.2B 67.2B
Avg 31.1B 34.9B
Low 31.0B 33.3B

Revenue Growth

Revenue Growth 202620272028
High
9.8%
116.2%
Avg
9.3%
12.3%
Low
8.9%
7.1%

EPS Forecast

EPS 202620272028
High 1.62 1.83
Avg 1.51 1.67
Low 1.44 1.48

EPS Growth

EPS Growth 202620272028
High
-9.7%
20.9%
Avg
-15.6%
10.2%
Low
-20.0%
-2.2%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.